英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
---|---|---|---|---|---|---|
Hecogenin
|
467-55-0 |
海柯吉宁
|
海柯皂苷元 (海柯吉宁;海可吉宁;番麻皂素;辛酸己酯;核柯配基;海可吉宁 (25R)-5Α-螺甾(烷)-3Β-醇-12-酮;蕃麻皂甙元;蕃麻皂素
|
C27H42O4 |
430.62 | 207-392-4 |
9,9-Bis(4-hydroxyphenyl)fluorene
|
3236-71-3 |
双酚芴
|
9,9-双(4羟基苯基)芴;9,9'-双(4-羟苯基)芴、双酚芴;4,4'-(9-亚芴基)二苯酚;双酚芴(>98%,BR);9,9-双(4-羟苯基)芴,4,4-(9-芴)二苯酚;双酚芴 ;双酚芴,9-二(4-羟基苯基)芴;9,9-二(4-羟苯基)芴
|
C25H18O2 |
350.41 | 406-950-6 |
4-Cyanoindole
|
16136-52-0 |
4-氰基吲哚
|
4-氰基吲哚;4-氰基吲哚 含水52%,86%;4-氰基吲哚 108G;4-氰基吲哚 (+4°C);4-氰基吲哚,97%
|
C9H6N2 |
142.15734 | 627-196-6 |
N-BOC-3-PYRROLIDINEACETIC ACID
|
175526-97-3 |
1-BOC-3-吡咯烷乙酸
|
1-BOC-3-吡咯烷乙酸;N-BOC-3-四氢吡咯乙酸;N-叔丁氧羰基吡咯烷-3-乙酸;N-BOC-3-吡唑乙酸;N-BOC-3-乙酸吡咯烷;1-BOC-吡咯烷-3-乙酸;1-N-BOC-3-乙酸吡咯烷;N-BOC-3-吡咯烷乙酸
|
C11H19NO4 |
229.27 | |
5-Chloronicotinic acid
|
22620-27-5 |
5-氯烟酸
|
5-氯烟酸,97%;5-氯烟酸;5-氯吡啶-3-羧酸;3-氯-5-吡啶甲酸;5-氯烟酸 1G;5-氯烟酸
|
C6H4NO2Cl |
157.55446 | |
3,5-Difluorophenol
|
2713-34-0 |
3,5-二氟苯酚
|
3,5-二氟苯酚;3,5-二氟苯酚,98%
|
C6H4F2O |
130.093 | 608-047-4 |
BOC-D-4,4'-BIPHENYLALANINE
|
128779-47-5 |
BOC-D-4,4'-二苯基苯胺
|
SACUBITRIL(LCZ696);BOC-D-4,4'-二苯基苯胺;BOC-D-4,4'-联苯丙氨酸;N-叔丁氧羰基-3-(4-联苯基)-D-丙氨酸;丁氧羰基-3-(4-苯基)D-丙氨酸;BOC-D-4,4'-联苯基丙氨酸;沙库比曲缬沙坦杂质;BOC-D-4,4'-BIPHE-OH
|
C20H23NO4 |
341.40092 | |
1-Boc-3-cyano-4-oxopyrrolidine
|
175463-32-8 |
1-Boc-3-氰基-4-吡咯烷酮
|
3-氰基-4-氧代吡咯烷-1-甲酸叔丁酯;1-Boc-3-氰基-4-吡咯烷酮;1-N-BOC-3-氰基-吡咯烷酮;1-N-叔丁氧羰基-4-氰基-3-吡咯烷酮;4-氧-3-氰基-1-N-BOC-吡咯烷;1-BOC-3-氰-4-吡咯烷酮,98%;3-氰-4-吡咯烷酮;1-BOC-3-氰基-4-吡咯烷
|
C10H14N2O3 |
210.22976 | 700-004-9 |
PASIREOTIDE
|
396091-73-9 |
帕西瑞肽
|
帕西瑞肽;帕瑞肽;PASIREOTIDE 帕瑞肽;SOM 230;SOM 320;门冬氨酸帕瑞肽
|
C58H66N10O9 |
1047.2 | |
(S)-3-Amino-1-N-Boc-piperidine
|
625471-18-3 |
(S)-1-Boc-3-氨基哌啶
|
S-1-BOC-3-氨基哌啶(CAS号:625471-18-3);(S)-1-叔丁氧羰基-3-氨基哌啶;(S)-1-Boc-3-氨基哌啶;(S)-1-N-Boc-3-氨基-哌啶;(S)-1-BOC-3-胺基哌啶;(S)-(+)-3-氨基-1-BOC-哌啶;(S)-1-叔丁氧羰基-3-氨哌啶;(S)-3-氨基-1-哌啶羧酸叔丁酯
|
C10H20N2O2 |
200.28 | 613-056-1 |
Fexofenadine Hydrochloride
|
153439-40-8 |
盐酸非索非那定
|
alpha,alpha-二甲基-4-[1-羟基-4-[4-(羟基二苯甲基)-1-派啶]丁基]-苯乙酸盐酸盐;非索那定盐酸盐;盐酸非索非那定;FEXOFENADINE-D11旽CL;非索芬那定盐酸盐;索那定盐酸盐;非索非那定盐酸盐;盐酸非索非那定USP
|
C32H39NO4·HCl |
538.13 | |
(R)-3-(3-Fluoro-4-morpholin-4-ylphenyl)-2-oxo-5-oxazolidinyl)methyl methansulfonate
|
174649-09-3 |
(R)-N-[3-(3-氟-(4-吗啉基)苯基)-2-氧代-5-唑烷基]甲醇甲磺酸酯
|
利奈唑胺相关杂质;(R)-N-[3-(3-氟-(4-吗啉基)苯基)-2-氧代-5-唑烷基]甲醇甲磺酸酯;(R)-N-[3-(3-氟-(4-吗啉基)苯基)-2-氧代-5-噁唑烷基]甲醇甲磺酸酯;(R)-N-[3-(3-氟-4-(4-吗啉)苯基)-2-氧-5-噁唑烷基]甲醇甲磺酸酯;(R)-N-[3-(3-氟-(4-吗啉)苯基)-2-氧-5-噁唑烷基]甲醇;(R)-N-[3-(3-氟-(4-吗啉基)苯基)-2-氧代-5-噁唑烷基]甲醇甲磺酸酯 1KG;利奈唑胺相关化合物;利奈唑胺USP RC D
|
C15H19FN2O6S |
374.384563 | 1592732-453-0 |
Ruxolitinib
|
941678-49-5 |
鲁索利替尼
|
鲁索利替尼杂质;RUXOLITINIB (INCB18424);CS-163;(BETAR)-BETA-环戊基-4-(7H-吡咯并[2,3-D]嘧啶-4-基)-1H-吡唑-1-丙腈;选择性 JAK1,JAK2 蛋白酪氨酸激酶抑制剂;酪氨酸蛋白激酶抑制剂;鲁索利替尼;Β-环戊基-4-(7H-吡咯并[2,3-D]嘧啶-4-基)-(ΒR)-1H-吡唑-1-丙腈
|
C17H18N6 |
306.371 | 1312995-182-4 |
6-AMINO-1,2,3,4-TETRAHYDRO-ISOQUINOLINE
|
72299-67-3 |
6-氨基-1,2,3,4-四氢异喹啉
|
6-氨基-1,2,3,4-四氢异喹啉;1,4-四氢-6-氨基异喹啉
|
C9H12N2 |
148.20498 | |
Ramipril
|
87333-19-5 |
雷米普利
|
雷米普利(标准品);N-[1(S)-乙氧羰基-3-苯丙基]-(S)-丙氨酰基-顺桥-2-氮杂二环[3,3,0]辛烷-3(S)-羧酸;雷米普利;(S)-2-[N-(1-乙氧羰基-3-苯基-丙基)丙氨酰基]-2-氮杂二环[3.3.0]辛烷-3-羧酸;聚醚胺类产品;雷米普利相关化合物;[2S-[1[R^<*>^ (R^<*>^)],2Α,3ΑΒ,6ΑΒ]]-1-[2-[[1-(乙氧羰基)-3-苯基丙基]氨基]-1-氧丙基]八氢环戊烷并[B]吡咯-3-羧酸
|
C23H32N2O5 |
416.51 | |
(S)-Benzyl 2-(N-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoate
|
137863-20-8 |
缬沙坦苄酯
|
缬沙坦相关物C;N-戊酰基-N-[[2'-(1H-四唑-5-基)[1,1'-联苯]-4-基]甲基]-L-缬氨酸苄酯;原研CGP 49841;缬沙坦 CGP49841;缬沙坦EP杂质B;缬沙坦USP相关物质C;缬沙坦杂质CGP49841;VALSARTAN-1
|
C31H35N5O3 |
525.6413 | 604-047-3 |
1-((1S,2S)-1-Hydroxy-1-(4-hydroxyphenyl)propan-2-yl)-4-phenylpiperidin-4-ol
|
134234-12-1 |
CP 101606
|
崔索普地;曲索罗地 INTG;曲索罗地;CP-101;606;CP 101606;CP101606;(1S,2S)-1-[4-羟苯基]-2-(4-羟基-4-苯哌啶基)-1-丙醇
|
C20H25NO3 |
327.417 | |
2,2'-[(4-Amino-3-nitrophenyl)imino]bisethanol hydrochloride
|
94158-13-1 |
4-氨基-3-硝基苯胺-N,N-二乙醇盐酸盐
|
HC 红 13 号;4-氨基-3-硝基苯胺-N,N-二乙醇盐酸盐;HC 红 NO. 13;染料红13
|
C10H16ClN3O4 |
277.70474 | 303-083-4 |
4-Amino-3-bromopyridine
|
13534-98-0 |
4-氨基-3-溴吡啶
|
4-氨基-3-溴吡啶(CAS号:13534-98-0);4-氨基-3-溴吡啶;4-氨基-3-溴嘧啶;4-氨基-3-溴吡啶,98%;3-溴-4-胺吡啶;3-溴-4-吡啶胺;3-溴吡啶-4-胺;4-氨基-3-溴吡啶 3-溴-4-氨基吡啶
|
C5H5N2Br |
173.0106 | 628-420-5 |
TAE684
|
761439-42-3 |
5-氯-N2-[2-甲氧基-4-[4-(4-甲基-1-哌嗪基)-1-哌啶基]苯基]-N4-[2-[(1-甲基乙基)磺酰基]苯基]-2,4-嘧啶二胺
|
5-氯-N2-[2-甲氧基-4-[4-(4-甲基-1-哌嗪基)-1-哌啶基]苯基]-N4-[2-[(1-甲基乙基)磺酰基]苯基]-2,4-嘧啶二胺;TAE684 (NVP-TAE684);NVP-TAE684;5-CHLORO-2-N-{2-METHOXY-4-[4-(4-METHYLPIPERAZIN-1-YL)PIPERIDIN-1-YL]PHENYL}-4-N-[2-(PROPANE-2-SULFONYL)PHENYL]PYRIMIDINE-2,4-DIAMINE
|
C30H40N7O3SCl |
614.2017 |